FENNEC PHARMACEUTICALS INC (FENC) Institutional Ownership
None of the superinvestors we track currently report FENNEC PHARMACEUTICALS INC (FENC) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in FENNEC PHARMACEUTICALS INC (FENC), this page will show asset manager ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2025 | 1 | $154,000 | 20,000 |
| Q3 2025 | 1 | $99,216 | 10,600 |
| Q1 2024 | 1 | $1,556 | 139,900 |
| Q2 2021 | 1 | $148 | 20,284 |
| Q2 2020 | 1 | $1,119 | 134,000 |
| Q1 2020 | 1 | $452 | 76,096 |
| Q4 2019 | 1 | $154 | 23,800 |
| Q1 2019 | 1 | $151 | 31,100 |
| Q2 2018 | 1 | $421 | 34,800 |
| Q1 2018 | 1 | $421 | 34,800 |
Related FENC Institutional Insights:
- FENC Institutional Ownership & Insiders Activity
- FENC Institutional Ownership & 13F Activity
- FENC Top Institutional Shareholders
- FENC Institutional Buying Activity
- FENC Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- FENC Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings